ARTVArtiva Biotherapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 11920
Ticker: ARTV
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2024-07-19
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: ARTV

Detail

Enriched 2026-08-14 20:47

Market cap: $563,703,095.13
Shares outstanding (class): 48,890,121
Shares outstanding (weighted): 48,890,121
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 115
Location: SAN DIEGO, CA
Homepage: https://www.artivabio.com
Description: Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).

Market cap and share counts drift.

Funds holding this security

8 funds · 8 positions · $1.83M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$954.4K	0.00%	148,199 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$383.1K	0.00%	59,487 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$225.4K	0.18%	35,000 NS	FIGI
Simplify Propel Opportunities ETF Simplify Exchange Traded Funds	SURI	$149.6K	0.22%	23,230 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$57.0K	0.00%	8,845 NS	FIGI
Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST	—	$51.6K	0.00%	8,018 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$5.9K	0.00%	915 NS	FIGI
Total Stock Market Index Trust John Hancock Variable Insurance Trust	—	$3.1K	0.00%	483 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERARTV
FIGI_COMPOSITEBBG00VPZJ0F9
FIGI_SHARE_CLASSBBG00VPZJ0G8
CIK0001817241
ISINUS04317A1079
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Artiva Biotherapeutics is a biotech company developing cell therapies, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.